Literature DB >> 11938480

Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies.

Gordon Gladman1, Earl D Silverman, Lily Luy, Christine Boutin, Carl Laskin, Jeffrey F Smallhorn.   

Abstract

The objectives of this study are to assess the incidence of congenital complete heart block (CCHB) in pregnant women who are anti-Ro and/or La positive. Between January, 1988 and July 1997, 118 pregnancies in 105 women were assessed by fetal echo at 18, 24, and 32 weeks' gestation. Of these 105, 96 had no history of a previous fetus with CCHB; 11(12 pregnancies) a history of a pregnancy with CCHB; and 4 a previous child with cutaneous neonatal lupus erythematosus (CNLE). The 102 pregnancies in 96 women with anti-Ro and/or anti-La antibodies and no history of a previous child with NLB, resulted in 100 live-births with no CCHB. There was 1 dilated cardiomyopathy at 6 months, 1 child with CCHB, and 1 with sclerosis of the endocardium. No case of CCHB was observed in 102 pregnancies without a previous history of CCHB. These results suggest that the risks of CCHB, without a prior history are low.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11938480     DOI: 10.1055/s-2002-23555

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  12 in total

1.  Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Authors:  Peter M Izmirly; Amit Saxena; Mimi Y Kim; Dan Wang; Sara K Sahl; Carolina Llanos; Deborah Friedman; Jill P Buyon
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

2.  Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.

Authors:  Peter M Izmirly; Nathalie Costedoat-Chalumeau; Cecilia N Pisoni; Munther A Khamashta; Mimi Y Kim; Amit Saxena; Deborah Friedman; Carolina Llanos; Jean-Charles Piette; Jill P Buyon
Journal:  Circulation       Date:  2012-05-24       Impact factor: 29.690

Review 3.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

4.  Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.

Authors:  Marta Tonello; Ariela Hoxha; Elena Mattia; Alessandra Zambon; Silvia Visentin; Alessia Cerutti; Anna Ghirardello; Ornella Milanesi; Amelia Ruffatti
Journal:  Clin Rheumatol       Date:  2017-02-15       Impact factor: 2.980

5.  Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.

Authors:  Peter M Izmirly; Carolina Llanos; Lela A Lee; Anca Askanase; Mimi Y Kim; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2010-04

Review 6.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

7.  Outcome of prenatally diagnosed isolated congenital complete atrioventricular block treated with transplacental betamethasone or ritodrine therapy.

Authors:  Taiyu Hayashi; Masahide Kaneko; Ki-Sung Kim; Yoshihiko Eryu; Takahiro Shindo; Takayoshi Isoda; Atsuko Murashima; Yushi Ito; Haruhiko Sago
Journal:  Pediatr Cardiol       Date:  2008-07-26       Impact factor: 1.655

8.  Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.

Authors:  Peter Izmirly; Mimi Kim; Deborah M Friedman; Nathalie Costedoat-Chalumeau; Robert Clancy; Joshua A Copel; Colin K L Phoon; Bettina F Cuneo; Rebecca E Cohen; Kimberly Robins; Mala Masson; Benjamin J Wainwright; Noel Zahr; Amit Saxena; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2020-07-21       Impact factor: 24.094

9.  Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

Authors:  Carolina Llanos; Peter M Izmirly; Margaret Katholi; Robert M Clancy; Deborah M Friedman; Mimi Y Kim; Jill P Buyon
Journal:  Arthritis Rheum       Date:  2009-10

Review 10.  Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus.

Authors:  Deborah M Friedman; Ann Rupel; Jill P Buyon
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.